FOXA vs INKT · P/E 14, rev $17.13B vs $59.1M cap
Fox Corp Class A (FOXA) versus Mink Therapeutics Inc (INKT) — a side-by-side from cached financials, not a winner call.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Mink Therapeutics Inc (INKT) is a biotechnology company listed on US.
Latest reported FOXA revenue for 2026-06-30 was $17.13B. Net income was $1.73B. Revenue was up 5.1% from 2025-06-30 to 2026-06-30. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
INKT does not have a complete income-statement cache yet.
FOXA currently screens at market cap $24.50B and trailing P/E 14.1. INKT currently screens at market cap $59.1M.
Not investment advice. Open the FOXA and INKT stock pages for the full models.
Not investment advice.